Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ligand Pharmaceuticals
Biotech
Ovid sells some royalty rights to Takeda-partnered seizure drug
Ovid Therapeutics has sold off part of the royalty rights to its Takeda-partnered seizure med in order to fund its operations into 2026.
James Waldron
Oct 18, 2023 8:00am
Roche taps new North American diagnostics chief—Chutes & Ladders
Dec 9, 2022 9:30am
Ligand takes a crack at SPAC to buoy spun-off antibody business
Mar 24, 2022 11:07am
Ligand to spin off J&J-partnered antibody unit with $70M funding
Feb 18, 2022 10:45am
HitGen picks up Vernalis' drug hunters from Ligand for $25M
Oct 12, 2020 10:59am
Ligand snags Roche-partnered drug in Icagen buyout
Feb 12, 2020 10:05am
